EXEL News 3.35 04/21/2014 21:10:32 Exelixis Inc (EXEL)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Exelixis Inc (EXEL) 3.35 $EXEL

Exelixis to Release First Quarter 2014 Financial Results on Thursday, May 1, 2014
Business Wire - Mon Apr 21, 3:06PM CDT
Exelixis, Inc. (NASDAQ: EXEL) will release its first quarter 2014 financial results on Thursday, May 1, 2014 after the markets close. The announcement will be followed by a live conference call and webcast at 5:00 p.m. EDT/ 2:00 p.m. PDT. During the presentation, Exelixis management will discuss the Company's financial results and provide a general business update.

1 of These 3 Cratering Biotechs is a Buy
George Budwell, The Motley Fool - Motley Fool - Fri Apr 18, 5:30PM CDT
At the start of the year, the theme seemed to be that biotech was in for another banner year, propelled by a suite of newly launch drugs that would go on to become blockbusters. These rosy prognostications were made despite broad-based biotech funds...

3 Stocks Under $10 to Trade for Breakouts
at The Street - Wed Apr 09, 5:00AM CDT
These under-$10 stocks are within range of triggering breakout trades.

European Commission Approves Exelixis Inc.'s Therapy for Thyroid Cancer
ACCESSWIRE - Fri Apr 04, 1:00PM CDT
Exelixis Inc. (NASDAQ:EXEL) enjoyed robust stock volume Apr. 3, with 4,756,727 shares changing hands.

Why I Bought Exelixis
Sean Williams, The Motley Fool - Motley Fool - Fri Apr 04, 11:05AM CDT
Some days as a biotech investor, no matter how savvy you think you are, you just have to bury your head in the sand because you're bound to experience a bad day. That's what happened last week to shareholders of Exelixis , a company I've been very...

Morning Movers in Biotech: Celgene Corporation, Mylan, Inc. and Exelixis, Inc.
George Budwell, The Motley Fool - Motley Fool - Fri Apr 04, 8:00AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Celgene Corporation ,  Mylan  , and Exelixis  .  Mylan up on possible takeover of rival Swedish Pharma  Shares of drugmaker Mylan are up over 11% in...

Are These 3 Biotechs Bad News Buys?
Dan Carroll, The Motley Fool - Motley Fool - Thu Apr 03, 8:30AM CDT
March wasn't kind to many of biotech's hottest names. From Geron to Exelixis , many of biotech's most talked-about stocks suffered headache-inducing falls over the past month. Biotech's had a good run lately with the market's rise, and while...

Biotech Stock Roundup: Biogen Drug Approved, Exelixis Tumbles on Study Update - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 02, 9:43AM CDT
Biotech companies continued to witness a decline in share prices last week.

Exelixis Continues On
Brian Orelli, The Motley Fool - Motley Fool - Mon Mar 31, 6:42PM CDT
Shares of Exelixis got hit hard last week after the company said its clinical trial testing Cometriq in prostate cancer would continue. While the continuation of a trial would normally be a non-event -- we'll get the final data before the end of...

Hot Stock: Exelixis, Shares Gain 5.2% (EXEL)
Comtex SmarTrend(R) - Mon Mar 31, 10:12AM CDT
Exelixis (NASDAQ:EXEL) is one of today's best performing low-priced stocks, up 5.2% to $3.56 on 1.6x average daily volume. Exelixis has traded 7.4 million shares thus far today, vs. average volume of 4.6 million shares per day. The stock has outperformed the Dow (5.2% to the Dow's 0.7%) and outperformed the S&P 500 (5.2% to the S&P's 0.8%) during today's trading.

Which Biotech Blow-Up Is a Bad-News Buy?
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sun Mar 30, 1:00PM CDT
On this edition of Market Checkup , Motley Fool health-care analysts David Williamson and Michael Douglass take a look at two of the weeks biggest biotech losers, and why one of them could make an interesting buy today. Shares of Exelixis were...

5 of Last Week's Biggest Losers
Rick Munarriz, The Motley Fool - Motley Fool - Sun Mar 30, 7:30AM CDT
There's never a shortage of losers in the stock market. Let's take a closer look at five of this past week's biggest sinkers. Company March 28 Weekly Loss Exelixis   $3.38 46% MannKind ...

3 Horrendous Health-Care Stocks This Week
Keith Speights, The Motley Fool - Motley Fool - Sat Mar 29, 7:00AM CDT
Spring might have sprung this week, but plenty of investors aren't feeling warm and fuzzy. That's especially the case for shareholders of this week's three horrendous health0care stocks. One of these stocks disappointed the market by simply...

Why Red Hat, Caesars Entertainment, and Exelixis Tumbled Today
Dan Caplinger, The Motley Fool - Motley Fool - Fri Mar 28, 7:30PM CDT
Favorable economic news helped send the stock market higher despite the usual pre-weekend jitters on Wall Street, as larger gains earlier in the day gave way to traders once again choosing not to hold onto positions in light of geopolitical...

Exelixis Inc's Comet Fails To Dazzle
Stephen D., Simpson,, The Motley Fool - Motley Fool - Fri Mar 28, 8:30AM CDT
Astronomers have grown very cautious over the years about predicting which comets will brighten the night skies, as all too many have failed to live up to expectation. Small biotech Exelixis '  own comet, the COMET-1 study of cabozantinib in...

Exelixis' Cometriq Approved in the EU - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 5:00PM CDT
Exelixis received approval for Cometriq in the EU for the treatment of progressive, unresectable locally advanced or metastatic medullary thyroid carcinoma (MTC).

Trade-Ideas: Exelixis (EXEL) Is Today's "Dead Cat Bounce" Stock
at The Street - Thu Mar 27, 8:45AM CDT
Trade-Ideas LLC identified Exelixis (EXEL) as a "dead cat bounce" (down big yesterday but up big today) candidate

King Digital Crushed In Its First Day of Trading; Exelixis Shares Fall 40 Percent
ACCESSWIRE - Wed Mar 26, 11:11PM CDT
King Digital Entertainment Plc (NYSE: KING) - For an in-depth report on King Digital Entertainment Plc follow: www.BullTrends.com/stockquote/KING

Why Exelixis, ReneSola, and Capstone Turbine Tumbled Today
Dan Caplinger, The Motley Fool - Motley Fool - Wed Mar 26, 7:30PM CDT
On Wednesday, stock market investors saw renewed fears about the sustainability of the five-year-old bull market, as heightened tensions between Russia and Ukraine contradicted the hopes that the conflict would quietly fade after Russia's annexation...

Talk About High Clinical Trial Expectations
Brian Orelli, The Motley Fool - Motley Fool - Wed Mar 26, 6:32PM CDT
Exelixis fell nearly 40% today on word that the company was continuing its phase 3 trial testing Cometriq in prostate cancer patients after the Independent Data Monitoring Committee took an interim peek at the data. On the surface, the news...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 354

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 342

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 73

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 103

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 423

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 562

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 344

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 585

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 129

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading

Top 5 Most Recently Viewed Articles

Unisync Triumphs at NAUMD Awards, Showcasing Innovation and Leadership

Updated Category News Views 181

Unisync Celebrates Major Recognition at NAUMD Awards Unisync Corp. (TSX: UNI) is thrilled to announce its recent achievements at the esteemed NAUMD (Network Association of Uniform Manufacturers and Distributors) Annual Convention, where it received four significant awards, showcasing its commitment to excellence in the managed uniform services industry. This remarkable...

Continue Reading
Key Economic Insights: Fed Chair Prospects and Global Data Releases

Updated Category News Views 264

Key Economic Insights for the Week Ahead The upcoming week presents a wealth of important economic information and events that could shape market expectations and financial strategies. From Federal Reserve leadership changes to significant global economic indicators, here’s what to anticipate. Potential Fed Chair Nomination With the resignation of the current Fed Chair...

Continue Reading
Understanding Investor Sentiments Surrounding AST SpaceMobile

Updated Category News Views 353

Investor Sentiment Towards AST SpaceMobile AST SpaceMobile (NYSE: ASTS) has seen a notable change in its short interest recently, with a decrease of 3.58% reported. This highlights a shift in investor sentiment, emphasizing how the market views the telecommunications innovator. Currently, approximately 45.07 million shares have been sold short, representing 20.75% of the...

Continue Reading
Insights into NuScale Power's Market Position and Trends

Updated Category News Views 163

Understanding NuScale Power's Market Sentiment NuScale Power (NYSE: SMR) has experienced notable changes in its short interest recently. The latest report indicates that the short percent of float has decreased by 6.75%, showcasing a decline in bearish sentiment towards the company. Currently, 26.80 million shares have been sold short, translating to 20.16% of all regular...

Continue Reading
BTQ Technologies and QBits Unveil Quantum-Secure Custody Infrastructure

Updated Category News Views 226

BTQ Technologies and QBits Launch Groundbreaking Initiative BTQ Technologies, in collaboration with QBits, is set to revolutionize the digital asset landscape with the development of the world's first quantum-secure custody treasury infrastructure. This partnership aims to leverage the innovative capabilities of the Quantum Canary Network, which will act as a public...

Continue Reading